In addition, multiple meta-analyses showed that CXCL12 expression improved the prognosis of breast cancer patients, which was consistent with our results that CXCL12 had a reverse causal association with breast cancer (Samarendra et al., 2017; Liu et al., 2018). This evidence concerns the gene CXCL12 and breast cancer.